FORMULATION AND METHOD FOR PREVENTING URINARY TRACT INFECTIONS
20200060324 ยท 2020-02-27
Inventors
Cpc classification
A23L33/125
HUMAN NECESSITIES
A23V2002/00
HUMAN NECESSITIES
A23L33/105
HUMAN NECESSITIES
A23V2200/32
HUMAN NECESSITIES
A23V2200/32
HUMAN NECESSITIES
A23V2002/00
HUMAN NECESSITIES
International classification
A23L33/125
HUMAN NECESSITIES
Abstract
A prophylaxis for preventing or reducing the occurrence of urinary tract infections in humans includes a formulation of vitamin C, D-mannose, cranberry extract, and pineapple extract. In a preferred embodiment, the formulation includes about 750 mg vitamin C, about 2000 mg D-mannose powder, about 1000 mg cranberry extract, and about 1000 mg pineapple extract. Additives, such as preservatives, binding materials, dyes, flavoring agents, and other excipients may also be present. A method of preventing or reducing the occurrence of urinary tract infections in a human involves administering vitamin C, D-mannose, cranberry extract, and pineapple extract to the human in a solid, dry dosage form on a daily basis.
Claims
1. A formulation comprising the following components, in combination with acceptable excipients or additives: vitamin C; D-mannose powder; cranberry extract; and pineapple extract.
2. An oral dosage unit comprising the formulation of claim 1.
3. The formulation of claim 1, having the following composition: about 750 mg vitamin C; about 2000 mg D-mannose powder; about 1000 mg cranberry extract; and about 1000 mg pineapple extract.
4. A prophylaxis for preventing or reducing the occurrence of urinary tract infections, comprising: an oral dosage unit including therapeutically effective amounts of vitamin C, D-mannose powder, cranberry extract, pineapple extract, and acceptable additives and excipient.
5. The prophylaxis of claim 4, wherein the oral dosage unit is formulated as a dry delivery system.
6. The prophylaxis of claim 5, wherein the oral dosage form is selected from the group consisting of pills, capsules, gel caps, tablets, and caplets.
7. The formulation of claim 4, having the following composition: about 750 mg vitamin C; about 2000 mg D-mannose powder; about 1000 mg cranberry extract; and about 1000 mg pineapple extract.
8. A method of preventing or reducing the occurrence of urinary tract infections, comprising administering to a subject a formulation comprising, in combination with acceptable additives and excipients: vitamin C; D-mannose powder; cranberry extract; and pineapple extract.
9. The method according to claim 8, wherein the formulation is administered in an oral dosage form.
10. The method according to claim 9, wherein the formulation is administered in a dry delivery form.
11. The method according to claim 10, wherein the formulation is administered in a dosage form selected from the group consisting of capsules, tablets, and caplets.
12. The method according to claim 8, wherein the formulation has the following composition: about 750 mg vitamin C; about 2000 mg D-mannose powder; about 1000 mg cranberry extract; and about 1000 mg pineapple extract.
13. The method according to claim 8, wherein: the subject is an adult human; and administering the formulation comprises administering about 9500 mg per day on a daily basis.
14. The method according to claim 8, wherein: the subject is a human child; and administering the formulation comprises administering about 4750 mg per day, every day.
Description
DETAILED DESCRIPTION
[0007] As required, detailed embodiments of the present invention are disclosed herein; however, it is to be understood that the disclosed embodiments are merely exemplary of the invention that may be embodied in various and alternative forms. Therefore, specific functional details disclosed herein are not to be interpreted as limiting, but merely as a representative basis for teaching one skilled in the art to variously employ the present invention.
[0008] A natural homeopathic preparation for preventing or reducing the occurrence of urinary tract infections in humans comprises a formulation of vitamin C, D-mannose, cranberry extract, and pineapple extract. In a preferred embodiment, the formulation comprises about 750 mg vitamin C, about 2000 mg D-mannose powder, about 1000 mg cranberry extract, and about 1000 mg pineapple extract. Additives, such as preservatives, binding materials, dyes, flavoring agents, and other excipients may also be present.
[0009] The vitamin C, D-mannose, cranberry extract, and pineapple extract are preferably initially obtained in powdered form, blended, and formulated into a dry oral dosage form such as a pill, capsule, chewable tablet, gel cap, or caplet.
[0010] A method of preventing or reducing the occurrence of urinary tract infections according to the present disclosure comprises administering to an adult human approximately 9500 mg per day, every day, of the formulation described above. The formulation is preferably in the form of two dosage units (ie. tablets), wherein each unit includes about 750 mg vitamin C, about 2000 mg D-mannose powder, about 1000 mg cranberry extract, and about 1000 mg pineapple extract. Both dosage units may be taken together, or one dosage unit may be taken twice a day. Alternatively, the method may comprise comprises administering to a human child approximately 4750 mg per day of the same formulation.
[0011] When taken daily at the dosages described above, the formulation will lower the pH of the patient's urine, thereby suppressing bacterial growth, improving urine odor, and preventing or reducing the frequency of urinary tract infections.
[0012] While exemplary embodiments are described above, it is not intended that these embodiments describe all possible forms of the invention. Rather, the words used in the specification are words of description rather than limitation, and it is understood that various changes may be made without departing from the spirit and scope of the invention. Additionally, the features of various implementing embodiments may be combined to form further embodiments of the invention.